Hard-Shelled Glycol Chitosan Nanoparticles for Dual MRI/US Detection of Drug Delivery/Release: A Proof-of-Concept Study.

Gd(III) complexes MRI nanobubbles relaxometry theranostics ultrasound imaging

Journal

Nanomaterials (Basel, Switzerland)
ISSN: 2079-4991
Titre abrégé: Nanomaterials (Basel)
Pays: Switzerland
ID NLM: 101610216

Informations de publication

Date de publication:
01 Aug 2023
Historique:
received: 23 06 2023
revised: 26 07 2023
accepted: 27 07 2023
medline: 12 8 2023
pubmed: 12 8 2023
entrez: 12 8 2023
Statut: epublish

Résumé

This paper describes a novel nanoformulation for dual MRI/US in vivo monitoring of drug delivery/release. The nanosystem was made of a perfluoropentane core coated with phospholipids stabilized by glycol chitosan crosslinked with triphosphate ions, and it was co-loaded with the prodrug prednisolone phosphate (PLP) and the structurally similar MRI agent Gd-DTPAMA-CHOL. Importantly, the in vitro release of PLP and Gd-DTPAMA-CHOL from the nanocarrier showed similar profiles, validating the potential impact of the MRI agent as an imaging reporter for the drug release. On the other hand, the nanobubbles were also detectable by US imaging both in vitro and in vivo. Therefore, the temporal evolution of both MRI and US contrast after the administration of the proposed nanosystem could report on the delivery and the release kinetics of the transported drug in a given lesion.

Identifiants

pubmed: 37570545
pii: nano13152227
doi: 10.3390/nano13152227
pmc: PMC10420971
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Bioconjug Chem. 2020 Aug 19;31(8):2008-2020
pubmed: 32628454
Nanoscale Res Lett. 2019 Jan 16;14(1):24
pubmed: 30649655
Haematologica. 2023 Jul 01;108(7):1861-1872
pubmed: 36172817
Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4607-12
pubmed: 9539785
Ultrason Sonochem. 2019 Sep;56:37-45
pubmed: 31101274
Biomed Res Int. 2019 Jul 14;2019:9480193
pubmed: 31392217
Nanomedicine (Lond). 2017 May;12(9):991-1009
pubmed: 28327075
Skin Pharmacol Physiol. 2010;23(3):164-70
pubmed: 20110767
Int J Pharm. 2017 May 15;523(1):176-188
pubmed: 28330735
Phys Med Biol. 2012 May 7;57(9):2787-802
pubmed: 22510713
Front Bioeng Biotechnol. 2020 Dec 07;8:586874
pubmed: 33365305
Pharmaceutics. 2022 Jan 31;14(2):
pubmed: 35214073
Curr Pharm Biotechnol. 2012 Mar;13(4):609-22
pubmed: 22214503
Mol Imaging. 2018 Jan-Dec;17:1536012118778216
pubmed: 30213222
J Control Release. 2014 Nov 10;193:202-13
pubmed: 24845129
RSC Adv. 2022 Apr 5;12(17):10504-10513
pubmed: 35425014
J Med Chem. 2004 Jul 1;47(14):3629-41
pubmed: 15214790
Ultrasound Med Biol. 2000 Sep;26(7):1177-89
pubmed: 11053753
Small. 2010 Jan;6(1):12-21
pubmed: 19844908
Expert Opin Drug Deliv. 2010 Jul;7(7):795-809
pubmed: 20446858
Mar Drugs. 2021 Feb 15;19(2):
pubmed: 33672056
Adv Drug Deliv Rev. 2012 Oct;64(13):1394-416
pubmed: 22728642
Front Pharmacol. 2020 Jan 31;10:1650
pubmed: 32082157
RSC Adv. 2021 Apr 6;11(21):12915-12928
pubmed: 35423829
Thyroid. 2016 May;26(5):705-16
pubmed: 26906083
Chem Rev. 1999 Sep 8;99(9):2293-352
pubmed: 11749483
Chem Commun (Camb). 2014 Apr 4;50(26):3453-6
pubmed: 24553970
Drug Deliv Transl Res. 2022 Aug;12(8):2007-2018
pubmed: 35672651
Front Immunol. 2023 Jun 08;14:1200310
pubmed: 37359561
Sci Rep. 2017 Jul 14;7(1):5370
pubmed: 28710468
Adv Mater. 2015 Jan 27;27(4):655-61
pubmed: 25472627
Onco Targets Ther. 2019 Mar 06;12:1841-1850
pubmed: 30881036
J Magn Reson Imaging. 2018 Dec;48(6):1610-1616
pubmed: 30475452
Front Pharmacol. 2019 Sep 11;10:1001
pubmed: 31572183
J Control Release. 2019 Jan 10;293:144-154
pubmed: 30503398
Ther Deliv. 2016;7(2):117-38
pubmed: 26769397
Methods. 2017 Nov 1;130:4-13
pubmed: 28552267
Magn Reson Med. 2017 Oct;78(4):1523-1532
pubmed: 27791281
Endocr Relat Cancer. 2017 Jun;24(6):275-286
pubmed: 28487350
Chem Rev. 2015 Oct 14;115(19):10907-37
pubmed: 26166537
Colloids Surf B Biointerfaces. 2015 May 1;129:39-46
pubmed: 25819364
Expert Rev Mol Diagn. 2012 Nov;12(8):841-55
pubmed: 23249202
Front Pharmacol. 2018 Oct 31;9:1230
pubmed: 30429787
Nanomedicine (Lond). 2020 Dec;15(30):2901-2916
pubmed: 33300812
Adv Cancer Res. 2018;139:57-84
pubmed: 29941107
R Soc Open Sci. 2016 Aug 3;3(8):160063
pubmed: 27853587
Ultrasound Med Biol. 2019 Sep;45(9):2502-2514
pubmed: 31248638
Nanotechnology. 2019 May 24;30(21):214004
pubmed: 30654342
Eur J Pharm Sci. 2012 Mar 12;45(4):436-41
pubmed: 21896328
J Control Release. 2012 Jul 20;161(2):328-37
pubmed: 22626940
Theranostics. 2018 Feb 2;8(5):1327-1339
pubmed: 29507623
PLoS One. 2016 Dec 21;11(12):e0168553
pubmed: 28002459
Molecules. 2020 Apr 30;25(9):
pubmed: 32365941
Ultrasonics. 2023 Aug;133:107056
pubmed: 37269682
Biomed Mater Eng. 2015;26 Suppl 1:S911-6
pubmed: 26406092
Biomaterials. 2012 Jan;33(1):247-55
pubmed: 21993236

Auteurs

Simona Baroni (S)

Molecular and Preclinical Imaging Centers, Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126 Torino, Italy.

Monica Argenziano (M)

Department of Drug Science and Technology, University of Torino, Via P. Giuria 9, 10125 Torino, Italy.

Francesca La Cava (F)

Molecular and Preclinical Imaging Centers, Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126 Torino, Italy.

Marco Soster (M)

Department of Drug Science and Technology, University of Torino, Via P. Giuria 9, 10125 Torino, Italy.

Francesca Garello (F)

Molecular and Preclinical Imaging Centers, Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126 Torino, Italy.

David Lembo (D)

Department of Clinical and Biological Sciences, University of Torino, S. Luigi Gonzaga Hospital, Regione Gonzole, 10, 10043 Orbassano, Italy.

Roberta Cavalli (R)

Department of Drug Science and Technology, University of Torino, Via P. Giuria 9, 10125 Torino, Italy.

Enzo Terreno (E)

Molecular and Preclinical Imaging Centers, Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126 Torino, Italy.

Classifications MeSH